纤维化
肾
肌成纤维细胞
串扰
医学
免疫系统
肾脏疾病
癌症研究
生物信息学
生物
免疫学
病理
内科学
物理
光学
作者
N. Yamashita,Rafael Kramann
标识
DOI:10.1016/j.tem.2023.09.001
摘要
Kidney fibrosis is the final common pathway of virtually all chronic kidney diseases (CKDs) and is therefore considered to be a promising therapeutic target for these conditions. However, despite great progress in recent years, no targeted antifibrotic therapies for the kidney have been approved, likely because the complex mechanisms that initiate and drive fibrosis are not yet completely understood. Recent single-cell genomic approaches have allowed novel insights into kidney fibrosis mechanisms in mouse and human, particularly the heterogeneity and differentiation processes of myofibroblasts, the role of injured epithelial cells and immune cells, and their crosstalk mechanisms. In this review we summarize the key mechanisms that drive kidney fibrosis, including recent advances in understanding the mechanisms, as well as potential routes for developing novel targeted antifibrotic therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI